Questions for Future Research
Q: Because healthy oligodendrocyte progenitor cells are important for the child’s developing brain, how could further characterization of NG2 isoforms help prevent drugs from damaging those beneficial cells?
Q: Could NG2-binding peptides cross the blood-brain barrier to deliver anti-cancer therapies precisely to tumor sites?
Source: “The Role of NG2 Proteoglycan in Glioma.” S. Yadavilli, E.I. Hwang, R. J. Packer, and J. Nazarian. Published by Translational Oncology on February 2016.
https://innovationdistrict.childrensnational.org/wp-content/uploads/2016/09/R@GNG2DIPG-Image-e1496433328865.jpg 200 300 Diedtra Henderson https://innovationdistrict.childrensnational.org/wp-content/uploads/2017/05/Innovation-District-Logo-tagline.jpg Diedtra Henderson2016-02-21 10:35:162017-06-03 14:43:56The role of NG2 proteoglycan in glioma
You might also like
Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape
2016 Neurobiology of Disease in Children Symposium: neurofibromatosis features Children’s National expert
Roger Packer, M.D., elected Pediatric Co-Chair by the National Cancer Institute’s Brain Malignancies Steering Committee